Unapproved ibutamoren product warning


The TGA has issued an alert due to an undeclared ingredient linked to a range of serious health outcomes The Therapeutic Goods Administration (TGA) says ‘Pharmatech’ branded MK-677 capsules (containing ibutamoren) should not be taken, as they may pose a serious risk to health.  TGA Laboratory testing found that the capsules contained undeclared metandienone, also

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous State announces deadline for free FluMist program
Next Off-label quetiapine linked to safety concerns